Provided by Tiger Trade Technology Pte. Ltd.

Amgen

421.51
-2.1300-0.50%
Post-market: 425.283.77+0.89%19:38 EDT
Volume:3.13M
Turnover:1.32B
Market Cap:226.97B
PE:26.18
High:426.59
Open:424.01
Low:420.63
Close:423.64
52wk High:447.03
52wk Low:283.00
Shares:538.48M
Float Shares:536.99M
Volume Ratio:1.10
T/O Rate:0.58%
Dividend:9.80
Dividend Rate:2.32%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:19.42
PE(LYR):29.62

Loading ...

Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong

Dow Jones
·
Yesterday

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Amgen price target raised to $500 from $450 at Scotiabank

TIPRANKS
·
Sep 29

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Reuters
·
Sep 29

Scotiabank Raises Amgen Price Target to $500 From $450, Sector Outperform Rating Kept

MT Newswires Live
·
Sep 29

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

TradingKey
·
Sep 28

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 28

Dow's 500-Point Rally Highlighted by Gains in Shares of Microsoft, Sherwin-Williams Co.

Dow Jones
·
Sep 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)

TIPRANKS
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Dow Jones
·
Sep 24

Leerink Partners Remains a Hold on Amgen (AMGN)

TIPRANKS
·
Sep 24

Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build

TradingKey
·
Sep 23

Amgen: Strengthening Pipeline and Long-Term Growth Upside Support Buy Rating and Unchanged $450 Price Target

TIPRANKS
·
Sep 23

Piper Sandler Keeps Their Buy Rating on Amgen (AMGN)

TIPRANKS
·
Sep 23

Jefferies Adjusts Amgen Price Target to $410 From $367, Maintains Hold Rating

MT Newswires Live
·
Sep 23

Scotiabank Sticks to Its Buy Rating for Amgen (AMGN)

TIPRANKS
·
Sep 23

Amgen Underperform Maintained as Dazodalibep Data Uncertainty Limits Upside; $317 Price Target Unchanged

TIPRANKS
·
Sep 23

US Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals

Reuters
·
Sep 23

Amgen Inc. Stock Advances 4.3%, Outperforms Peers

Dow Jones
·
Sep 23